OSA Therapy Response Assessment

Advanced Brain Monitoring, Inc.

South Korea

Advanced Brain Monitoring (ABM), founded in 1997 and based in Carlsbad, California, is a pioneering neurotechnology firm revolutionizing brain health diagnostics through non-invasive, EEG-based platforms and systems. The company specializes in portable, FDA-cleared neurodiagnostic systems that assist in early detection and treatment of neurodegenerative, neurological, psychiatric, and sleep-related disorders. With a strong intellectual property portfolio (24 granted patents), ABM’s product suite includes state-of-the-art EEG-based monitoring systems tailored for clinical, research, and clinical trial applications. The company has leveraged AI-driven analytics to provide automated biomarkers, enhancing medical decision-making for Alzheimer’s and Parkinson dementia, PTSD, sleep apnea, insomnia and many more. ABM’s solutions have been widely adopted across clinical, research institutions, and healthcare providers. Its continuous innovation in neurodiagnostics has resulted in 12 FDA-clearances, with 7 currently in active use supporting global patient care and research initiatives. ABM follows an in-house, comprehensive product development process—identifying unmet medical needs and pioneering new market applications—from initial concept and biomarker discover to fully validated products, creating a distinct competitive advantage.